Tomefa E. Asempa

Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing <i>Pseudomonas aeruginosa</i>

Christian M Gill, Maxwell J. Lasko, Tomefa E. Asempa et al. · Journal of Clinical Microbiology · 2020 · 72 citations · Full text

Metallo-β-lactamase resistance in Enterobacteriaceae is an artefact of currently utilized antimicrobial susceptibility testing methods

Tomefa E. Asempa, Kamilia Abdelraouf, David P. Nicolau · Journal of Antimicrobial Chemotherapy · 2019 · 51 citations

Damage‐associated molecular patterns stimulate interleukin‐33 expression in nasal polyp epithelial cells

Gina Paris, Tatyana Pozharskaya, Tomefa E. Asempa et al. · International Forum of Allergy & Rhinology · 2013 · 47 citations · Full text

Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists

Eric Wenzler, Mira Maximos, Tomefa E. Asempa et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2023 · 47 citations · Full text

Carbapenem-Nonsusceptible <i>Pseudomonas aeruginosa</i> Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents

Tomefa E. Asempa, David P. Nicolau, Joseph L. Kuti · Journal of Clinical Microbiology · 2019 · 35 citations · Full text